Area of research
Virology · Immunology
Research interest
Research interests include Virology, Biology, Simian immunodeficiency virus, Immunology, Immune system, and Human immunodeficiency virus (HIV).
Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life
Origin and Correlates of Viral Rebound in SIV-Infected Rhesus Macaques Following ART Discontinuation
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption
Acute-phase innate immune responses in SIVmac239-infected Mamu-B*08+ Indian rhesus macaques may contribute to the establishment of elite control
AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus
IL-21 and IFNα therapy rescues terminally differentiated NK cells and limits SIV reservoir in ART-treated macaques
CD8 Lymphocyte Depletion Enhances the Latency Reversal Activity of the SMAC Mimetic AZD5582 in ART-Suppressed Simian Immunodeficiency Virus-Infected Rhesus Macaques
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption
Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques
Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells
Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome
Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections
Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies
Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes
Derivation of simian tropic HIV-1 infectious clone reveals virus adaptation to a new host
Vaccine protection against SIVmac239 acquisition
Elevated <i>HLA-A</i> expression impairs HIV control through inhibition of NKG2A-expressing cells
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen
Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation
Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication
<i>Mamu-B*17</i> <sup>+</sup> Rhesus Macaques Vaccinated with <i>env</i> , <i>vif</i> , and <i>nef</i> Manifest Early Control of SIVmac239 Replication
Defining total-body AIDS-virus burden with implications for curative strategies
Early antibody therapy can induce long-lasting immunity to SHIV
A single gp120 residue can affect HIV-1 tropism in macaques